Have a personal or library account? Click to login
Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? Cover

Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

Open Access
|Mar 2022

Authors

Dorota Maria Borowicz

dorota.borowicz@wco.pl

Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland

Agnieszka Skrobała

Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland
Electroradiology Department, University of Medical Sciences, Poznan, Poland

Marta Kruszyna-Mochalska

Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland
Electroradiology Department, University of Medical Sciences, Poznan, Poland

Julian Malicki

Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland
Electroradiology Department, University of Medical Sciences, Poznan, Poland
DOI: https://doi.org/10.2478/raon-2022-0010 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 259 - 266
Submitted on: Oct 21, 2021
Accepted on: Jan 31, 2022
Published on: Mar 28, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.